Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Conjupro Biotherapeutics, Inc.
Pfizer
Dragonfly Therapeutics
ViroMissile, Inc.
Tizona Therapeutics, Inc
IDEAYA Biosciences
Adaptimmune
Oscotec Inc.
Novartis
National Institutes of Health Clinical Center (CC)
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Exelixis
MacroGenics
Incyte Corporation
Genentech, Inc.
Celldex Therapeutics
DEKA Biosciences
Columbia University
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Inhibrx Biosciences, Inc
The Affiliated Hospital of Qingdao University
Xencor, Inc.
Pfizer
Celldex Therapeutics
STCube, Inc.
Adaptimmune
Apexigen America, Inc.
Centre Georges Francois Leclerc
Emory University
Celldex Therapeutics
Fate Therapeutics
Mabpro, a.s.
Mirati Therapeutics Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
Revolution Medicines, Inc.
Imperial College London
Pfizer
Incyte Corporation
Five Prime Therapeutics, Inc.
MacroGenics
Weill Medical College of Cornell University
Shionogi Inc.